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1. Introduction 
Automated techniques for sequential degradation 
by the phenylisothiocyanate procedure of Edman [l] 
have greatly accelerated progress in the structural 
analysis of proteins. Conventional procedures for 
sequenator analysis, however, require 100-500 nmoles 
of protein for an extended egradation. Since many 
proteins of great biological interest are available only 
in trace amounts, more-sensitive s quencing 
approaches are urgently needed. 
We have developed amethod for automated 
sequence analysis of nanomole quantities of proteins 
in the presence of a synthetic polyamino-acid carrier. 
The carrier protects the protein from chemical and 
mechanical losses during the degradation and allows 
longer degradations on smaller amounts of material 
than can be achieved when the protein is sequenced 
alone. 
2. Experimental studies 
2.1. Synthesis of polyamino-acid carrier 
The carrier peptide H (Norleu-Arg)s,NH, was 
synthesized by the Merrifield [2] solid-phase 
procedure using the Beckman 990 synthesizer. The 
benzhydrylamine derivative of a poly (trifluoro- 
chloroethylene-g-styrene) resin (4.0 g) with 0.05 
mmole-NHs/g was used as the solid support [3]. An 
automated ouble-coupling procedure performed 
according to methods previously described [4] was 
used to assemble the peptide chain. N-&tertiary 
butyloxycarbonyl-L#-tosyl arginine was coupled 
directly with the solid-phase and then alternately 
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with N-cY-tertiarybutyloxycarbonyl-L-norleucine for 
a total of 54 residues. 
The peptide was cleaved from the resin with 
simultaneous removal of the tosyl protecting roup 
by treatment with hydrogen fluoride in the presence 
of anisole for 1 hr at 0°C. After removal of excess 
hydrogen fluoride and anisole, the peptide was 
extracted into dilute acetic acid and lyophilised. 
The crude peptide was purified by gel filtration on 
Bio-Gel P-6 in 1 M acetic acid, yielding 0.65 g of 
peptide, which was used in the sequence studies 
without further purification. 
2.2. Automated Edman degradations 
A Beckman Sequencer Model 890C was used for 
the automated Edman degradations. Reagents and 
solvents were obtained from Beckman Instruments, 
Palo Alto, California. A single-coupling, double- 
cleavage program based on that of Edman and Begg 
[l] with minor modifications was employed. 
Identifications of the phenylthiohydantoin (PTH) 
amino acid derivatives were made by previously 
reported gas-liquid chromatography and thin-layer 
chromatography s stems [5,6] . 
In preliminary experiments, a series of separate 
sequenator runs was carried out on 300-, 1 OO-, 25-, 
lO-, and 1 nmole samples of sperm-whale apomyo- 
globin. Repetitive yields calculated by gas 
chromatographic analysis of ‘stable’ PTH derivatives 
(valine, leucine) were regularly in the range 92%-94% 
for the 300 nmole and 100 nmole samples. Slightly 
lower yields (averaging 90%) were obtained at the 
25.nmole level. Runs carried out on the 10 nmole 
samples gave more variable, but clearly much lower, 
repetitive yields (80%=86%); usually, identifications 
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Fig. 1. Sequenator un on a 6 nmole sample of apomyoglob~ 
with and without the addition of 150 nanomoles of 
synthetic poly(norleu-arg) carrier, showing repetitive yields 
obtained by gas c~omato~ap~c analysis of stable phenyl- 
thiohydantoin derivatives (valine, alanine, and leucine). 
could not be clearly made beyond residue 11. Only 
the fast one or two residues could be identi~ed on 
the 1 nmole sample. 
In a second series of experiments, the apomyo- 
globin degradations were repeated with different 
sample amounts but with the addition of 1 SO-500 
nmoles of poly (norleu-arg) carrier, which was mixed 
with the protein sample before transfer into the 
spinning cup of the sequenator. No significant effect 
of the carrier on repetitive yields was noted with 
amounts of apomyoglobin i  excess of 50 nmoles, 
and a marginal effect was noted at the 25 nmole 
level. When the sample size was in the range l- 10 
nmoles, however, there was a marked improvement 
in yield in the presence of carrier. This effect is 
~lustrated in fig. 1 and table 1. Degradations were 
performed on 6 nmoles of apomyoglobin with and 
without the addition of 150 nmoles of carrier. In the 
absence of added carrier, identifications could not 
be made beyond residue 11. With the addition of 
carrier, positive identification of all residues was 
obtained for 21 cycles of degradation. 
3. Discussion 
When current sequenator methodolo~ is 
examined in detail, it becomes apparent that there 
are two different kinds of limitations to the 
sensitivity of the analysis. The first relates to the 
methods used to identify the amino acid derivatives 
obtained at each cycle of de~adation. The usual 
identification systems, based on gas chromatography, 
thin-layer chromatography, or amino acid analysis 
after regeneration of the free amino acid by hydrogen 
iodide [7], require approximately 5nmoles at each 
cycle for reliable detection of all residues. The use 
of ~~-s~ci~c-activity 35 S-phenylisothiocyanate in 
the degradation [8] or the use of more sensitive thin- 
layer c~omatograp~~ procedures [9] helps to 
Table 1 
Thin-Layer chromatography identification of PTH amino acids 
Residue No carrier Carrier Residue No carrier Carrier 
1 VAL VAL 11 
2 LEU (LEU)* 12 
3 SER SER 13 
4 GLU GLU 14 
5 GLY GLY 15 
6 GLU GLU 16 
7 TRP TRP 17 
8 faint GLN + GLU GLN + GLU 18 
9 - (LEU)* 19 











* Identification of leucine obscured by norleucine from carrier; leucines were identified and 
quantitated by gas chromatography (see fig. 1). 
?’ Pauly identification. 
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overcome this limitation and allows detection of 
F’TH amino acids at the 20-50 pmole level. The 
second limitation becomes apparent when attempts 
are made to degrade trace amounts of protein in the 
sequenator. There is a rapid fall in yield due to 
mechanical osses of material in the solvent washes 
and probably also to chemical side reactions. Hence, 
only comparatively short degradations are possible. 
In the approach described here, the protein is 
protected by the addition of a synthetic polyamino- 
acid carrier, poly(norleu-arg), which acts as a ‘sink 
for mechanical and chemical losses. This allows 
prolonged degradations to be carried out on less than 
10 nmoles of purified protein. 
It appears likely that the use of such carriers to 
achieve a ‘protected’ Edman degradation will be 
most helpful in structural work on proteins available 
only in nanomole amounts. Since the carrier 
methodology is quite compatible with the use of 
35 S-phenylisothiocyanate, the combination of both 
approaches hould allow even-further increases in 
sensitivity of analysis, and is currently being evaluated 
in our laboratory. 
In this study, the choice of a repeating copolymer 
of norleucine and arginine was dictated by several 
considerations. To avoid interference with identifica- 
tion of the unknown protein sequence, a carrier 
composed of non-naturally-occurring amino acids 
must be employed. The carrier should be reasonably 
polar so that it will dissolve readily in the coupling 
and cleavage reagents. The guanidino group, which 
is protonated and therefore highly polar in both the 
alkaline coupling buffer and the anhydrous fluoro- 
acid used for cleavage, confers such properties. 
Finally, it seemed desirable to have a carrier that 
would give rise to phenylthiohydantoin derivatives 
to protect both organic-phase and aqueous-phase 
derivatives at the conversion step. The first choice 
for a carrier that would fulfill all these criteria was a 
repeating copolymer of norleucine and homoarginine. 
Since the appropriate tertiarybutyloxcarbonyl- 
blocked derivative of homoarginine for the solid-phase 
synthesis was not commercially available, it was 
decided to substitute arginine for homoarginine to 
allow the general approach to be rapidly evaluated. 
Synthesis of the norleucine-homoarginine copolymer 
is in progress, and, obviously, there are many other 
possibilities for design of a carrier molecule still to 
be investigated. The length of the present carrier 
molecule is probably also not optimal since, after 
20-30 cycles of degradation, extractive losses of the 
shortened residual carrier start to become appreciable; 
use of a carrier of 80- 100 residues could avoid this 
problem. 
The principle of protected Edman degradation 
has a potentially broad application. Radioactive 
proteins, for example, may be sequenced at high 
sensitivity in the presence of nonradioactive carriers. 
Since the identifications are based on radioactivity, 
a natural protein can be used as the protecting agent. 
Using this approach, we recently determined the 
amino-terminal sequence of human proparathyroid 
hormone internally labeled with 3H and 14C amino 
acids, in the presence of a nonradioactive natural 
protein (apomyoglobin) as carrier [lo]. 
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